Creative Biolabs provides CM13 helper phage production services for research workflows that rely on helper phage support in phagemid-based display systems. Our service includes CM13 helper phage production, amplification, titering, purification, and analytical evaluation, with project discussions aligned to the intended use of the material in phage display-related studies.
CM13 is a helper phage used in phage display applications. It is a derivative of M13KO7 carrying the interference-resistant ir3B A→G mutation at position 8418 and is commonly described as functionally equivalent to VCSM13 in display-related use. In phagemid-based systems, helper phage quality can influence rescue efficiency and the overall consistency of downstream experimental steps, which makes helper phage preparation and evaluation an important part of many laboratory workflows.
CM13 helper phage support may be discussed for research projects involving:
We offer a focused set of CM13 helper phage support options that can be discussed individually or in combination, depending on the role of helper phage in the planned workflow. We keep the discussion tied to the actual experimental purpose, analytical priorities, and desired level of technical review.
| Service Area | Scope of Support |
|---|---|
| CM13 Production | Preparation of CM13 helper phage for research workflows |
| Amplification | Amplification support for helper phage-related studies |
| Titering | Phage titer assessment as part of preparation review |
| Purification | Discussion of purification options based on downstream needs |
| Analytical Support | Characterization and QC-related evaluation |
Our CM13 helper phage production service is centered on the preparation and amplification of CM13 for research workflows that depend on helper phage-mediated packaging and propagation. For projects that require more than a single preparation step, amplification can be discussed together with purification and characterization needs so that the service remains practical and experimentally relevant.
Titering support is available as part of CM13 preparation and evaluation. We also provide basic characterization options to help clients assess helper phage quality. Depending on the project, discussion may include:
Purification options can be discussed according to the intended research use of the CM13 preparation. The purification approaches include:
Different purification routes may be more suitable for different downstream priorities. For that reason, purification is best planned in relation to the experimental objective rather than treated as a fixed default step.
Quality evaluation is an important part of CM13 helper phage preparation, especially when the material will be used in phagemid-based display workflows. Our current service includes several analytical checkpoints that help characterize the preparation in a research-oriented and technically practical way.
| QC Item | Current Technical Basis |
|---|---|
| Virion Concentration | Determined by phage DNA concentration with UV spectrophotometry and calculated based on CM13 genome length |
| Phage Titer | Assessed by serial dilution followed by plating with TG1 cells in top agar |
| Infectivity | Considered as the ratio between phage titer and virion concentration |
| Gene II ORF Sequence | Verified by PCR amplification and sequencing |
At Creative Biolabs, we organize CM13 helper phage projects through a concise, research-focused workflow supported by our specialized experience in phage-related service development, practical understanding of display-oriented workflows, and integrated capabilities in production, purification, and analytical evaluation. This approach helps clients move from initial technical questions to a clearer and more workable experimental support plan.
We begin by clarifying the intended role of CM13 in the client's phage display workflow and defining whether the project requires production alone or a broader scope that includes amplification, purification, and analytical evaluation.
Once the service scope is defined, CM13 helper phage production is arranged according to the research objective. When needed, amplification is incorporated to support the planned experimental use and downstream workflow requirements.
If purification is required, the approach is selected based on the intended use of the CM13 preparation and the level of material refinement needed for the project. Available options may include size-exclusion chromatography, anion-exchange chromatography, CsCl gradient centrifugation, or PEG precipitation.
Relevant analytical checkpoints are then applied according to the agreed project scope. These may include virion concentration assessment, phage titer determination, infectivity evaluation, and Gene II ORF sequence verification to support technical review of the CM13 preparation.
Whether you need CM13 helper phage production alone or would like to explore amplification, purification, and analytical support as part of a broader display-oriented workflow, we are happy to discuss your research goals and service needs.
A concise initial inquiry is usually enough to start the discussion. Helpful details may include:
Researchers working with different helper phage systems may also be interested in the following services:
If your project involves a specific helper phage system or requires comparison across different helper phage options for phage display workflows, we welcome a technical discussion to help define a suitable research support strategy.
Can CM13 Be Discussed as a VCSM13 Replacement Option?
Yes. CM13 is commonly described as equivalent to VCSM13 helper phage and may be discussed as a replacement option in research workflows where that technical relationship is relevant. The final project discussion should still reflect the specific experimental context.
Can Purification and Analytical Support Be Discussed Together?
Yes. Purification and analytical support can be considered together during project planning so that the level of purification and the desired characterization are aligned with the intended research use of the CM13 preparation.
What Project Details Are Helpful When Submitting an Inquiry?
A short description of the intended phage display workflow, the role of CM13 in the experiment, and any known priorities related to production, purification, titering, or analytical assessment is usually helpful for the initial discussion.
Is This Service Suitable for Phagemid-Based Display Workflows?
Our service is intended for research workflows in which CM13 helper phage support is relevant to phagemid rescue, virion preparation, reamplification, or related display-oriented work. The exact fit should be reviewed against the goals of the project.
What Quality-Related Parameters Can Be Discussed for CM13 Preparations?
Current quality-related items described for this service include virion concentration, phage titer, infectivity, and Gene II ORF sequence verification. Additional analytical discussion should remain within the scientifically justified scope of the project.
Reference
Please kindly note that our services can only be used to support research purposes (Not for clinical use).
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.
